safranal has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, W; Lertnimitphun, P; Lu, Y; Pei, W; Xu, H; Yang, B; Yuan, M; Zhang, W; Zhang, X; Zheng, C; Zhou, H | 1 |
| Bukhari, SI; Dhar, MK; Kaul, S; Pattnaik, B; Rayees, S | 1 |
2 other study(ies) available for safranal and Asthma
| Article | Year |
|---|---|
Safranal Alleviated OVA-Induced Asthma Model and Inhibits Mast Cell Activation.
Topics: Allergens; Animals; Anti-Inflammatory Agents; Asthma; Cell Degranulation; Cyclohexenes; Cytokines; Disease Models, Animal; Disease Susceptibility; Female; Immunoglobulin E; Inflammation Mediators; Mast Cells; Mice; NF-kappa B; Ovalbumin; Signal Transduction; Terpenes | 2021 |
Safranal of Crocus sativus L. inhibits inducible nitric oxide synthase and attenuates asthma in a mouse model of asthma.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Cells, Cultured; Crocus; Cyclohexenes; Cytochromes c; Cytokines; Disease Models, Animal; Humans; Lung; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Plant Extracts; Terpenes | 2015 |